https://www.avient.com/sites/default/files/2022-03/Asia SEM Healthcare Product Selection Guide %281%29.pdf
PP OVERMOLDING HARDNESS REGULATORY STERILIZATION CHARACTERISTICS
Dynaflex™ G2706 28A USP Class VI, ISO 10993,
Food contact EtO Soft translucent grade,
grippy feel
Dynaflex™ G2711 43A USP Class VI, ISO 10993,
Food contact EtO Highly colorable solution,
grippy feel, low compression set
Versaflex™
CL2242 & CL2250 42A/ 50A USP Class VI, ISO 10993,
US Food contact EtO Clear boilable grades;
ABS, PC bondable
Versaflex™ G2705 N 60A USP Class VI, ISO 10993,
Food contact EtO/Steam High resilience,
low compression set
Versaflex™ HC3810 20A-90A USP Class VI, ISO 10993 EtO General purpose, unfilled
ABS, PC OVERMOLDING HARDNESS REGULATORY STERILIZATION CHARACTERISTICS
Versaflex™ OM1040 40A USP Class VI, ISO 10993 EtO Translucent
Versaflex™ OM3060 60A USP Class VI, ISO 10993 EtO Clear
VERSAFLEX™ CL AND DYNAFLEX™ TPEs
OVERMOLDING FOR
ERGONOMICS
• Adds good tactile surface with soft-touch feel
• Available in a variety of color effects and
textures
• Improves grip, cushion, and comfort
• Enhances functional performance like sealing
properties, vibration damping, oxygen
barrier, and scratch and abrasion resistance
• Reduces assembly costs, good processability
• Offers excellent adhesion to a wide range of
substrates
• Glucometers
• Medical tools overmolds
• Injector pens
• Analysis devices
VERSALLOY™ HC & VERSAFLEX™ HC TPEs
SEALING & RESEALING
• Rubbery feel and soft touch
• No coring, good puncture, and
resealability in static stoppers
• Meets low coefficient of friction
requirements in dynamic seals
• Low extractables
• Suitable to overmold onto polyolefins
• Sealing and resealing septum
• Seals and sanitary gaskets
• Syringe plungers and tips
MATERIAL DESCRIPTION HARDNESS REGULATORY STERILIZATION CHARACTERISTICS
Versalloy™
HC 9210-45N 45A USP Class VI EtO Good processability,
HC 9210-55N 55A USP Class VI EtO Good processability,
HC 9210-70N 70A USP Class VI EtO Good processability,
HC 9220-43N 43A USP Class VI,
ISO 10993-4/5 EtO Extrusion grade,
high temperature resistance
Versaflex™
HC 2110-35N 34A FDA, USP Class VI,
ISO 10993
Autoclave EtO
radiation Resealing, elevated comp set
Versaflex™
HC 2110-57B 57A FDA, USP Class VI,
ISO 10993
Autoclave EtO
radiation Low stiction
VERSAFLEX™ CL AND DYNAFLEX™ TPEs
HIGH CLARITY
GRADES WITHOUT
PLASTICIZERS
• Water clear grades formulated without
phthalate plasticizers
• Meets medical regulatory USP Class VI and
ISO 10993-4,5
• Food contact and FDA compliant
• Autoclave and radiation stable
• Low extractable
• High clarity (Haze 50 4.1, 100 4.5, 100 4, 70 6, 70
Tensile Modulus (MPa) 2200 2700 2600 2350 1820 1820
Flexural Strength (MPa) 80 90 104 86 68 68
Flexural Modulus (MPa) 2500 2700 2500 2300 1980 1590
HDT: 0.45, 1.8 (MPa) 110, 80 90, 80 100, 89 123, 100 123, 64 100, 70
UL-94 Rating @ 3.0 mm 5VA V-0 5VA V-0 HB V-0
UL-94 Rating @ 1.5 mm V-0 V-0 5VB V-0 HB V-0
UL-94 Rating @ 0.75 mm V-1 V-2 V-0 None None V-2
COMPETITIVE MATERIAL COMPARISON
ENGINEERED POLYMER FORMULATIONS
FOR HEALTHCARE
TRILLIANT™ HC THERMOPLASTICS
The family of Trilliant™ HC high-performance thermoplastics is formulated to meet the growing challenges
of medical devices and equipment.
MATERIAL DESCRIPTION BASE RESIN
Trilliant™ HC2020 Copolyester
Trilliant™ HC8910/8920 Polyketone/ABS blend
Trilliant™ HC2120 Tritan
Trilliant™ HC3120 PC
Trilliant™ HC5210 PP
Trilliant™ HC6010 PA6
Trilliant™ HC6610 PA66
Trilliant™ GRV-NP-110-W PA12
TRILLIANT™ HC THERMOPLASTICS
• Chemically resistant replacement for FR PC/ABS,
FR PC/PET & FR COPE, providing UL 94 Yellow
Card V-0 flame rating at 1.5 mm, V-1 at 0.75 mm
thicknesses for a broad color spectrum
• Outperforms PC/ABS, PC/PET and COPE in
resistance to common disinfectants
• Retains tensile strength after 72-hour exposure
to common hospital disinfectants, and shows
better long-term chemical resistance as
compared to PC blends and COPE
• Exhibits good impact and temperature resistance
• Available in natural grades, standard medical
colors, or custom pre-colored products
• Medical device housings
• MRI, X-ray, CT scanner components
• Surgical instruments such as staplers, dissectors,
scissors
• Auto-injector pen
TRILLIANT™ HC
ELECTRICALLY
CONDUCTIVE
FORMULATIONS
• Consistent conductivity ensures repeatable
part performance and minimizes failures
related to inconsistent electrical conductivity
• High flow and easy processing facilitate filling
of thin wall parts and multiple cavity tools,
which enable faster cycle times and lower
per-unit part costs
• Superior durability reduces breakage and
resultant scrap related costs
• Less tendency to flash results in improved
appearance and less fluid retention in or on
the tip, thus driving greater accuracy and less
potential for cross-contamination
• High strength produces parts with greater
stiffness and warp resistance, again
minimizing scrap-related costs
• Conductive pipette tips
TEST
TEMS
SPECIFIC
GRAVITY
MELT FLOW
RATE
(230OC,
2.16KG)
TENSILE
FLEXURAL
FLEXURAL
MODULUS
IMPACT
STRENGTH
NOTCHED,
IZOD
SURFACE
RESISTIVITY
Method ASTM D-792 ASTM D-1238 ASTM D-638 ASTM D-790 ASTM D-790 ASTM D-256 ASTM D-257
Unit -- g/10min MPa MPa MPa J/m Ohms/sq.
ST5200-8030
ESD BK001 1 5 27 52 1980 42 E3
ST5200-8035
ESD BK001 1 20 22 37 1460 150 E3
+86.21.60284888
www.avient.com
Copyright © 2021, Avient Corporation.
https://www.avient.com/sites/default/files/resources/FAQs%2520for%2520PolyOne%2520GHS%2520Requirements%2520Ver%252006%2520April%25202015.pdf
OSHA established a date of June 1, 2015 for those required to generate SDSs for their formulation or
mixture products to start using the new GHS format.
Distributors have until December 1, 2015 to
implement the same changes.
Complete implementation for suppliers and
employers will be required by December 1, 2018.
https://www.avient.com/sites/default/files/2022-08/Schedule 2 a_b_c - SCCs_0.pdf
Clause 1, Clause 2, Clause 3, Clause 6, Clause 7;
ii.
The details for “Table 1: Parties” shall be set out in Appendix to Schedules 2(a), (b), and
(c), Annex 1;
b.
Entering into this Addendum
1.
https://www.avient.com/sites/default/files/2024-01/Global Standard Response_Dec 2023.pdf
Standard handling time frame:
1 Business Day to
confirm receipt and
r .ecord it in our system
15 Business days to
analyze problem,
provide root cause
and action plan.
30 days to close
complaint
8
The overall processing times may vary depending on the complexity of the issue and resources needed.
Record Retention
Production records are stored for a minimum of 1 year.
ERP records are kept for a minimum of 5 years.
https://www.avient.com/company/policies-and-governance/it-systems-use-policy
9
10
Annex 1 - ISO 13485 certification for Mevopur manufacturing sites North America
& EMEA.
https://www.avient.com/sites/default/files/resources/PolyOne%2520IR%2520Presentation%2520Sidoti%2520wNonGAAP%2520Rec.pdf
Page 3
Strategy and Execution Drive Results
90%
$22
$24
PolyOne
Stock Price
50%
$18
$20
$22
S&P 500 (relative performance)
30%
$12
$14
$16
S&P 500 (relative performance)
‐10%
10%
$6
$8
$10
50%
‐30%
$0
$2
$4
$
|
‐50%$0
2006 2007 2008 2009 2010 2011 2012 2013
Page 4
Four Pillar Strategy
The World’s Premier Provider of SpecializedThe World s Premier Provider of Specialized
Polymer Materials, Services & Solutions
Page 5
Spartech – Compelling Strategic Rationale
• Spartech expands PolyOne’s specialty portfolio with adjacent
technologies in attractive end markets
Bolt on acquisition with opportunity for global expansion as only Bolt‐on acquisition with opportunity for global expansion, as only
6% of Spartech’s revenues are outside of North America
• PolyOne has a proven management team with a track record of
transformational success
• Preliminary synergy estimated at $65 million run rate by end of
3year 3
Significant opportunity to expand profitability by leveraging
PolyOne’s four pillar strategy
• Substantial potential share price appreciation for all
shareholders
f f ll / $ Accretive to EPS in first full year post‐acquisition / $0.50 once
synergies realized
Page 6
Mix Shift Highlights Specialty Transformation
Old
PolyOne Transformation
100%
2015
Target
80%
In
co
m
e*
65 – 75%40%
60%
f O
pe
ra
tin
g
34% 43% 45%
65 75%
20%
o
f
2%0%
2005 2008 2010 2012 2015
Specialty OI $5M $46M $87M $114M Target
*Operating Income excludes corporate charges and special items
JV's PP&S Distribution Specialty
Page 7
Proof of Performance
2007 2012 2015
“Where we were” “Where we are” “Where we Where we were Where we are expect to be"
1) Operating Income %
Specialty 3.2% 9.1% 12 – 16%
PP&S 6.1% 9.0% 9 – 12%
Distribution 3.0% 6.4% 6 – 7.5%
2) Specialty Platform
sss% of Operating Income 20% 45% 65 – 75%
3) ROIC* ( ft t ) 7% 11% 15%3) ROIC* (after‐tax) 7% 11% 15%
4) Adjusted EPS Growth** N/A 4 yr CAGR = 55% Double Digit
Expansion
*ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period
**4 yr EPS CAGR calculated using 2012 adjusted EPS vs 2008 adjusted EPS
Page 8
Proof of Performance
Spartech Opportunity
Intermediate
PolyOne Spartech Opportunity
2006 2012 Today Goal
“Where we
were”
“Where we
are”
“Where
Spartech is”*
“Where we
can go”were are Spartech is can go
Specialty
Operating
Margin
1.5% 9.1% 2.2% 8.0% – 10.0%
Margin
Page 9
*Pro Forma results include Spartech corporate allocations for FY12 ended November 3, 2012
PolyOne
14%
Latin
America
3% Distribution
2012 Revenues: $4.2 Billion* 2012 Revenues: $4.2 Billion*
United
States
14% 5%
PP&S
20%Specialty
57%
Building & HealthCare
1.02
1.20
$1.20
$1.40
ha
re
End Markets* EPS Growth
Construction
14%
17%
Industrial
9%
0.27 0 21
0.79
$0.40
$0.60
$0.80
$1.00
Ad
ju
st
ed
E
ar
ni
ng
s P
er
S
Electrical &
0.12
0.21 0.13
$0.00
$0.20
2006 2007 2008 2009 2010 2011 2012
Page 10
* Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms
Specialty
U it d
2012 Revenues: $2.4 Billion* Solutions
United
States
59%
9%
Latin
America
Building &
C t ti
HealthCare
o
f S
al
es
12-16%
End Markets* Expanding Profits
Construction
Electrical &
Industrial
15%
1.5%
3.2% 4.3%
5.3%
8.4% 9.1%
O
pe
ra
tin
g
In
co
m
e
Page 11
2006 2007 2008 2009 2010 2011 2012 2015
O
Target* Pro Forma includes FY2012 results for Spartech (11/03/12 YE) and Glasforms
Designed Structures and Solutions
United States
2012 Revenues: $0.85 Billion* Solutions
84%
Latin America
4% Building & Construction
Sign & Advertising
3%
Recreation & Leisure
Pool & Spa
1%
Distribution &
Thermoform
2% Operating Income % of Sales
2012 Revenue by Industry Segment* Expanding Profits**
Electrical & Electronics
23%Industrial
3%
2.2%
8 ‐ 10%
1%
HealthCare
2012 2015
Target
Page 12
*Pro Forma includes FY2012 results for Spartech (11/03/12 YE)
**Pro Forma results include Spartech corporate allocations for FY12
Positioned for Earnings Growth
2015 Target
Rev: $5B
Adj.
EPS: $1.20
Proforma Debt Maturities & Liquidity Summary – 12/31/12
(Reflecting Financing & Spartech Acquisition)
• Total Debt at 12/31/12
h
$1,010
$297
$360 $300
$400
Debt Maturities
As of December 31, 2012
($ millions)
Less: Cash
Net Debt
213
$797
$50
$297
$100
$200
• Available Liquidity
Cash $213
$800 Debt Maturities
As of December 31, 2012
P f f 2/13 Fi i
$50 $0
2015 2017 2020
Interest Rates: 7.500% 5.000% 7.375%
Cash
ABL Availability
Total Liquidity
$213
271
$484
$600
$400
$600
Proforma for 2/13 Financing
($ millions)
Total Liquidity
• Net Debt / EBITDA = 2.0x*
$484
$50
$360
$0
$200
• Net Debt / EBITDA = 2.35x**
$50$0
2015 2020 2023
Page 14
Interest Rates: 7.500% 7.375% 5.250%
*Assumes $65 million of synergies related to Spartech acquistion
**Assumes no synergies related to Spartech acquistion
Use of Cash
Share DividendsOrganic
G Acquisitions
• Repurchased 1 2
Repurchase
• Introduced a
Dividends
• Expanding our
Growth
T t th t d
Acquisitions
• Repurchased 1.2
million shares in
2012
• 20.0 million
shares are
il bl f
• Introduced a
quarterly dividend
in Q1 2011 and
increased in Q1
2012 (25%) and
Q1 2013 (20%)
• Expanding our
sales, marketing,
and technical
capabilities is top
priority
• Investing in
• Targets that expand our:
• Specialty offering
• End market presence
• Geographic footprint
available for
repurchase under
the current
authorization
Q1 2013 (20%)
• Objective of
maintaining and
growing
Investing in
operational and
LSS initiatives
(including synergy
capture)
• CAPEX
• Synergy opportunities
• Adjacent material solutions
Proforma Cash Balance = $213M
N t D bt / EBITDA* 2 0X
CAPEX
Net Debt / EBITDA* = 2.0X
*Adjusted EBITDA assumes synergies related to the Spartech acquisition are realized at close; preliminary synergies estimated at $65M and are expected to be achieved over a 3-year period
Page 15
Why Invest In PolyOne?
https://www.avient.com/sites/default/files/2022-05/Avient_ALL_Policies_2022_0.pdf
Bob Patterson
Chairman, President, and CEO
August 1, 2020
ENVIRONMENTAL POLICY
Avient Corporation conducts its operations in an environmentally
responsible manner that is protective of the communities in which we
operate.
Bob Patterson
Chairman, President, and CEO
August 1, 2020
Product Stewardship Policy
Product Stewardship plays a significant role in Avient’s sustainable and ethical
business practices.
https://www.avient.com/sites/default/files/2021-06/chemical-resistance-technical-bulletin.pdf
TEST METHOD
Fifteen bars of each material were placed into jigs at 1% and 2%
strain.
This procedure was completed by placing one 1/2 inch section
of rayon gauze at the apex of each bar, and soaking the gauze with the
disinfectant to saturate the material.
https://www.avient.com/sites/default/files/2021-06/fl.us-.datasheet-carbon-fiber.pdf
Equilibrium moisture regain @ 55% RH ** Creep @ 40%-58% ultimate tensile strength *** Shrinkage in dry air @ 177 C for 30 minutes
LOCATIONS
Headquarters, R&D, Manufacturing
FIBER-LINE® LLC
3050 Campus Drive
Hatfield, PA 19440
+1 215.997.9181
fiber@fiber-line.com
Manufacturing Operations
FIBER-LINE® LLC
280 Performance Drive SE
Hickory, NC 28602
+1 828.326.8700
fiber@fiber-line.com
EMEA & Asia Pacific Operations
FIBER-LINE® INTERNATIONAL B.V.
https://www.avient.com/sites/default/files/2021-06/fl.datasheet-kevlarr-distribution-program.pdf
Abrasion
Yarn on Yarn
Abrasion
Ultraviolet (UV)
Flame
Chemical
(Acid)
Chemical
(Alkali)
Chemical
(Organic Solvent)
P O X P P P P
LOCATIONS
Headquarters, R&D, Manufacturing
FIBER-LINE® LLC
3050 Campus Drive
Hatfield, PA 19440
+1 215.997.9181
fiber@fiber-line.com
Manufacturing Operations
FIBER-LINE® LLC
280 Performance Drive SE
Hickory, NC 28602
+1 828.326.8700
fiber@fiber-line.com
EMEA & Asia Pacific Operations
FIBER-LINE® INTERNATIONAL B.V.
https://www.avient.com/sites/default/files/2021-06/fl.datasheet-packingyarn.pdf
Product ID FIBER-LINE® Coating Base Fiber Nominal Yield Description
K9000 FIBER-LINE® Packcoat™ Kevlar®
660 FT/LB
(400 M/KG)
PFOA Free PTFE & Silicone oil
NX8400 FIBER-LINE® Packcoat™ Nomex®
787 FT/LB
(527 M/KG)
PFOA Free PTFE & Silicone oil
C24K14000 FIBER-LINE® Packcoat™ Carbon
383 FT/LB
(257 M/KG)
PFOA Free PTFE & graphite based
lubricant dispersion
C6K3600 FIBER-LINE® Packcoat™ Carbon
1675 FT/LB
(1125 M/KG)
PFOA Free PTFE, silicone oil, &
graphite based lubricant dispersion
PTFE6959 FIBER-LINE® Packcoat™ PTFE
1277 FT/LB
(867 M/KG)
PFOA Free PTFE & Silicone oil
POPULAR PACKING YARN PRODUCTS
LOCATIONS
Headquarters, R&D, Manufacturing
FIBER-LINE® LLC
3050 Campus Drive
Hatfield, PA 19440
+1 215.997.9181
fiber@fiber-line.com
Manufacturing Operations
FIBER-LINE® LLC
280 Performance Drive SE
Hickory, NC 28602
+1 828.326.8700
fiber@fiber-line.com
EMEA & Asia Pacific Operations
FIBER-LINE® INTERNATIONAL B.V.